The Effectiveness of Megadose Shinbaro Pharmacopuncture for Patients With Chronic Shoulder Pain
TerminatedNCT04222829
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is a prospective, case-control observational trial. The investigators will compare the Megadose Shinbaro Pharmacopuncture group to the control group to analyze the effectiveness of shoulder Megadose Shinbaro Pharmacopuncture.
Study details
- Official title
- Observational Study on Effectiveness of Megadose Shinbaro Pharmacopuncture for Patients With Chronic Shoulder Pain Due to the Shoulder Diseases
- Conditions
- Shoulder Joint Disorder
- Interventions
- Procedure: Megadose Shinbaro Pharmacopuncture
- Sponsor
- Jaseng Medical Foundation
- Start date
- 2019-12-04
- Primary completion
- 2021-06-01
- Sex
- All
- Age range
- from 19 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with NRS ≥ 4 for shoulder pain over 3weeks * Patients aged 19-70 years on the date they sign the consent form. * Patients who provide consent to participate in the trial and return the informed consent form Exclusion Criteria: * Patients who have been diagnosed with a severe disease that may cause shoulder pain, * Patients with progressive neurological deficit or with serious neurological symptoms caused by spinal cord compression. * Patients who visited a hospital in pain caused by a traffic accident. * Patients with a severe mental illness. * Patients who are difficult to complete the research participation agreement
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04222829